Analysis of the expression of PD-L1 in primary central nervous system lymphoma (PCNSL) tumor cells and surrounding normal tissue

Analysis of the expression of PD-L1 in primary central nervous system lymphoma (PCNSL) tumor cells and surrounding normal tissue - PD-L1 expression in PCNSL

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027729

Enrollment

Registered

2017-07-04

Start date

2017-07-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary central nervous system malignant lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: PCNSL cases diagnosed from January 1, 2000, to December 31, 2016

Exclusion criteria

Exclusion criteria: Insufficient material volume of surrounding normal tissues for immunohistochemistry

Design outcomes

Primary

Measure	Time frame
Analysis of the expression of PD-L1 in PCNSL tumor cells and surrounding normal tissue	—

Secondary

Measure	Time frame
Analysis of the expression of PD-L2 in PCNSL tumor cells and surrounding normal tissue and correlation between these expression and overall survival of the patients	—

Countries

Japan

Contacts

Public ContactShin-Ichi Miyatake

Osaka Medical College Cancer Center

neu070@osaka-med.ac.jp072-683-1221

Outcome results